Glenmede Trust’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-258
| Closed | -$10K | – | 2333 |
|
|
2020
Q3 | $10K | Buy |
258
+170
| +193% | +$6.59K | ﹤0.01% | 1893 |
|
|
2020
Q2 | $4K | Buy |
88
+12
| +16% | +$545 | ﹤0.01% | 2148 |
|
|
2020
Q1 | $4K | Hold |
76
| – | – | ﹤0.01% | 2738 |
|
|
2019
Q4 | $4K | Hold |
76
| – | – | ﹤0.01% | 2738 |
|
|
2019
Q3 | $4 | Buy |
76
+45
| +145% | +$2 | ﹤0.01% | 2726 |
|
|
2019
Q2 | $1 | Hold |
31
| – | – | ﹤0.01% | 3001 |
|
|
2019
Q1 | $1 | Sell |
31
-25
| -45% | -$1 | ﹤0.01% | 2980 |
|
|
2018
Q4 | $2 | Buy |
+56
| New | +$2 | ﹤0.01% | 2804 |
|